These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 34114701

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Positive intrathecal anti-Borrelia antibody synthesis: what are the implications for clinical practice? Clinical features and outcomes of 138 patients in a French multicenter cohort study.
    Naudion P, Raffetin A, Zayet S, Klopfenstein T, Baux E, Martinot M, Piroth L, Caumes E, Chirouze C, Bouiller K.
    Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):441-452. PubMed ID: 36806057
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of antibiotic treatment in children with Lyme neuroborreliosis - a retrospective study.
    Arnason S, Skogman BH.
    BMC Pediatr; 2022 Jun 09; 22(1):332. PubMed ID: 35676665
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.
    Ljøstad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, Mygland A.
    Lancet Neurol; 2008 Aug 09; 7(8):690-5. PubMed ID: 18567539
    [Abstract] [Full Text] [Related]

  • 9. Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study.
    Backman K, Skogman BH.
    BMC Pediatr; 2018 Jun 11; 18(1):189. PubMed ID: 29890951
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunoblot reactivity at follow-up in treated patients with Lyme neuroborreliosis and healthy controls.
    Dersch R, Sarnes A, Maul M, Minakowski O, Hottenrott T, Stich O, Rauer S.
    Ticks Tick Borne Dis; 2019 Jan 11; 10(1):166-169. PubMed ID: 30352738
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.
    Knudtzen FC, Nilsson AC, Hovius JW, Skarphedinsson S.
    Eur J Clin Microbiol Infect Dis; 2020 Aug 11; 39(8):1461-1470. PubMed ID: 32172371
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lyme neuroborreliosis with encephalitis; a systematic literature review and a Scandinavian cohort study.
    Knudtzen FC, Eikeland R, Bremell D, Quist-Paulsen E, Johansen IS, Solheim AM, Skarphédinsson S.
    Clin Microbiol Infect; 2022 May 11; 28(5):649-656. PubMed ID: 34768019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.